This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
Wuhan's startup scene is marked by a focus on advanced manufacturing and biotechnology. The city is home to new companies in fields ranging from semiconductors to electric vehicles.
Electric vehicle maker Voyah has raised CN¥5B in funding. Another company, smart technology platform Xingji Meizu, was founded in 2023 and has already secured CN¥2B.
Below is our list of 53 Wuhan startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Voyah builds a line of premium electric vehicles that incorporate autonomous driving technology. The automaker is focused on international expansion, introducing its luxury EVs to new global markets.
iRegene develops RNA interference (RNAi) therapies to treat complex neurodegenerative and rare diseases. The company's proprietary AI platform helps accelerate the discovery and development of these novel treatments.
Xingji Meizu Group creates a technology ecosystem that connects smartphones, vehicles, and AR smart glasses. They focus on deep software and hardware integration to deliver a seamless experience as users move between their personal devices and their car.
Polarisic creates high-performance chips focused on depth perception and low-light imaging. Their technology provides advanced visual sensing capabilities for electronics used in challenging lighting conditions.
ABclonal provides the global life sciences community with a growing catalog of high-quality antibodies and molecular enzyme reagents. Their tools are designed to accelerate scientific research and the development of new diagnostics.
Chime Biologics provides contract development and manufacturing (CDMO) services for the global biopharmaceutical sector. Their team offers end-to-end support, helping clients navigate the entire lifecycle from early drug development to large-scale commercial production.
Cobot builds an intelligent operating system designed to control and manage industrial robots. Their platform combines deep learning and 3D vision to help robots perform complex manipulation tasks in sectors like automotive and logistics.
XW Laboratories discovers and develops potential new medicines for treating neurological disorders. The company's pipeline is built entirely from its own internal research, creating a portfolio of proprietary drug candidates.
Nekcom develops immersive video games for PC, console, and virtual reality platforms. The studio is behind titles like the post-apocalyptic action RPG Showa American Story and the horror puzzle game DYING: Reborn.
Yangtze Memory Technologies develops and manufactures 3D NAND flash memory chips used in a wide range of data storage applications. Their work establishes them as a key producer of semiconductor memory solutions for both consumer electronics and enterprise systems.
Our top picks offer just a glimpse into the city's growing startup community. Many more companies are making big moves, especially in fields like biotech, healthcare, and advanced manufacturing.
From brand new ventures to established companies, these startups have collectively raised billions to fund their growth. Here is a look at the other companies shaping Wuhan's startup scene.
| Startup | Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Healthcare | 2015 | CN¥183M | Series C | |
| Manufacturing | 2006 | CN¥2.7B | Undisclosed | |
| Biotech | 2016 | $237.4M | Series C | |
| Healthcare | 2009 | $100M | Venture Round | |
| Biotech | 2019 | $1.4M | Seed | |
| Hardware | 2019 | CN¥800M | Venture Round | |
| Hardware | 2016 | CN¥180M | Series D | |
| Fintech | 2024 | CN¥60M | Seed | |
| Mobility | 2020 | $14.1M | Series B | |
| AI | 2015 | $30.5M | Venture Round | |
| Mobility | 2016 | CN¥2.8B | Series B | |
| Biotech | 2013 | CN¥500M | Series A | |
| Biotech | 2010 | CN¥1B | Series C | |
| Hardware | 2021 | CN¥480M | Series A | |
| Data | 2001 | CN¥200M | Venture Round | |
| AI | 2000 | CN¥320M | Series D | |
| Biotech | 2010 | CN¥450M | Series C | |
| Manufacturing | 1994 | CN¥856.8M | Private Equity | |
| AI | 2011 | $46.3M | Series C | |
| Healthcare | 2013 | $80.9M | Series C | |
| AI | 2017 | $80M | Venture Round | |
| Other | — | CN¥1.5B | Venture Round | |
| Data | 2013 | $28.5M | Series B | |
| AI | 2014 | $15.2M | Series B | |
| Logistics | 2021 | CN¥450M | Series A | |
| Hardware | 2001 | CN¥90M | Venture Round | |
| AgTech | 2019 | CN¥100M | Seed | |
| Biotech | 2018 | CN¥200M | Series B | |
| Food | 2020 | CN¥150M | Series A | |
| Manufacturing | 2015 | CN¥800M | Series C | |
| Enterprise | 2015 | CN¥200M | Series C | |
| Infrastructure | 2000 | CN¥100M | Series A | |
| Data | 2014 | $38.2M | Series D | |
| Hardware | 2012 | CN¥100M | Series A | |
| Mobility | 2015 | $181.5M | Series D | |
| Mobility | 2022 | CN¥200M | Series A | |
| Hardware | 2011 | CN¥215M | Series C | |
| Healthcare | 2013 | CN¥280M | Venture Round | |
| Media | 2018 | $44.6M | Series B | |
| Healthcare | 2015 | CN¥100M | Series B | |
| Enterprise | 2013 | $87.3M | Series C | |
| Media | 2016 | CN¥150M | Venture Round | |
| Media | 2008 | CN¥567M | Private Equity |
